Guggenheim Capital’s Repros Therapeutics Inc. RPRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-20,254
| Closed | -$20K | – | 3040 |
|
2016
Q1 | $20K | Sell |
20,254
-64,583
| -76% | -$63.8K | ﹤0.01% | 2828 |
|
2015
Q4 | $103K | Sell |
84,837
-13,189
| -13% | -$16K | ﹤0.01% | 2833 |
|
2015
Q3 | $728K | Sell |
98,026
-7,427
| -7% | -$55.2K | ﹤0.01% | 2266 |
|
2015
Q2 | $755K | Buy |
105,453
+2,126
| +2% | +$15.2K | ﹤0.01% | 2367 |
|
2015
Q1 | $887K | Buy |
103,327
+22,974
| +29% | +$197K | ﹤0.01% | 2295 |
|
2014
Q4 | $802K | Buy |
+80,353
| New | +$802K | ﹤0.01% | 2328 |
|
2014
Q3 | – | Sell |
-11,953
| Closed | -$206K | – | 3249 |
|
2014
Q2 | $206K | Sell |
11,953
-1,141
| -9% | -$19.7K | ﹤0.01% | 2854 |
|
2014
Q1 | $233K | Buy |
13,094
+2,170
| +20% | +$38.6K | ﹤0.01% | 2783 |
|
2013
Q4 | $200K | Buy |
10,924
+1,290
| +13% | +$23.6K | ﹤0.01% | 2788 |
|
2013
Q3 | $258K | Buy |
+9,634
| New | +$258K | ﹤0.01% | 2592 |
|